{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Negative Fosfomycin (\u22644 - \u2265256 \u03bcg/mL)",
        "VITEK 2 ASTGN Fosfomycin (\u22644 - \u2265256 \u03bcg/mL)",
        "VITEK 2 AST-GN Fosfomycin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K222430",
    "Predicate Device Reference 510(k) Number(s)": [
        "K191766"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "August 10, 2022",
    "Summary Letter Received Date": "August 11, 2022",
    "Submission Date": "August 9, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Fosfomycin"
    ],
    "Specimen Type(s)": [
        "Gram negative bacilli",
        "Aerobic Gram-negative bacilli",
        "Escherichia coli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility test",
        "Microdilution minimum inhibitory concentration (MIC) technique"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Microdilution"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-GN Fosfomycin quantitative antimicrobial susceptibility test for Gram negative bacilli using VITEK 2 systems.",
    "Indications for Use Summary": "For in vitro quantitative determination of Gram negative bacilli susceptibility to fosfomycin as a laboratory aid using VITEK 2 and VITEK 2 Compact Systems; active in vitro and in clinical infections: Escherichia coli.",
    "fda_folder": "Microbiology"
}